IL157730A0 - Benzimidazole compounds for modulating ige and inhibiting cellular prolifration - Google Patents
Benzimidazole compounds for modulating ige and inhibiting cellular prolifrationInfo
- Publication number
- IL157730A0 IL157730A0 IL15773002A IL15773002A IL157730A0 IL 157730 A0 IL157730 A0 IL 157730A0 IL 15773002 A IL15773002 A IL 15773002A IL 15773002 A IL15773002 A IL 15773002A IL 157730 A0 IL157730 A0 IL 157730A0
- Authority
- IL
- Israel
- Prior art keywords
- prolifration
- benzimidazole compounds
- inhibiting cellular
- modulating ige
- ige
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27526001P | 2001-03-12 | 2001-03-12 | |
US10/090,044 US6759425B2 (en) | 1999-10-21 | 2002-02-27 | Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation |
PCT/US2002/006801 WO2002072090A1 (en) | 2001-03-12 | 2002-02-28 | Benzimidazole compounds for modulating ige and inhibiting cellular proliferation |
Publications (1)
Publication Number | Publication Date |
---|---|
IL157730A0 true IL157730A0 (en) | 2004-03-28 |
Family
ID=26781599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15773002A IL157730A0 (en) | 2001-03-12 | 2002-02-28 | Benzimidazole compounds for modulating ige and inhibiting cellular prolifration |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR20040025903A (en) |
IL (1) | IL157730A0 (en) |
-
2002
- 2002-02-28 IL IL15773002A patent/IL157730A0/en unknown
- 2002-02-28 KR KR10-2003-7011844A patent/KR20040025903A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20040025903A (en) | 2004-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL364230A1 (en) | Benzimidazole compounds for modulating ige and inhibiting cellular proliferation | |
EP1546157A4 (en) | PHENYL-AZA-BENZIMIDAZOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION | |
PL370909A1 (en) | Cis-imidazolines as mdm2 inhibitors | |
HK1061854A1 (en) | Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors | |
IL157657A0 (en) | Metalloproteinase inhibitors | |
IL157570A0 (en) | Metalloproteinase inhibitors | |
GB0128287D0 (en) | Novel method and compounds | |
EP1537079A4 (en) | PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION | |
PL363391A1 (en) | Phthalayinone-piperidino-derivatives as pde4 inhibitors | |
IL157650A0 (en) | Metalloproteinase inhibitors | |
EP1434772A4 (en) | Compounds and methods | |
HUP0401756A3 (en) | Substituted benzimidazole compounds and their use | |
GB0120818D0 (en) | Heterocyclic compounds | |
AU2002359694A8 (en) | Compounds and methods | |
GB0126889D0 (en) | Compounds and their uses | |
GB0125708D0 (en) | Novel compounds and processes | |
GB0221438D0 (en) | Processes and compounds | |
EP1478655A4 (en) | METHODS AND MATERIALS FOR MODULATING ENaC-BETA | |
IL157730A0 (en) | Benzimidazole compounds for modulating ige and inhibiting cellular prolifration | |
EP1379240A4 (en) | Compounds and methods | |
GB0101134D0 (en) | Inhibitors | |
GB0128453D0 (en) | Inhibitors | |
GB0101135D0 (en) | Inhibitors | |
AU2002367320A8 (en) | Methods and materials for modulating task-3 | |
GB0213995D0 (en) | Compounds and processes |